Skip to main content
Back to Lux Capital

Lux Capital's Pharmaceutical Portfolio

Browse 11 Pharmaceutical companies funded by Lux Capital. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
11
Total Funding in Pharmaceutical
$1.4B

Pharmaceutical Portfolio Companies (11)

Export
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

San Diego, United States
August 2025
$60.1M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMachine LearningPharmaceutical

Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

Lexington, United States
June 2022
$30.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Salt Lake City, United States
June 2024
$200.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Kallyope uses the science of gut-brain biology to create medicines that transform human health.

New York, United States
May 2023
$8.2M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.

Boulder, United States
September 2025
$150.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.

Vilnius, Lithuania
February 2025
$25.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyNeurosciencePharmaceuticalTherapeutics

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

Seattle, United States
November 2022
$96.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical

Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.

La Jolla, United States
October 2025
$825.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

Industrial AutomationManufacturingPersonal HealthPharmaceuticalRobotics

Multiply Labs deploys advanced robotics technology to manufacture personalized pharmaceutical capsules.

San Francisco, United States
April 2021
$20.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceuticalTherapeutics

A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform

Palo Alto, United States
August 2020
$15.7M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Capella Bioscience engages in the discovery and development of monoclonal antibodies.

London, United Kingdom
March 2016
$15.5M
Series A

Founder Contacts

30,000+ verified contacts

Explore Lux Capital's Full Portfolio

View all companies funded by Lux Capital across every industry and funding stage.

View Full Lux Capital Portfolio